Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 745
Ph III recruiting: 79
Growth YoY: +22.3%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 601–650 of 864 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00006214	Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate	completed	Phase 2	63	Alliance for Clinical Trials in OncologyOTHER	2	Jul 13, 2016	clinicaltrials
NCT00032006	Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer	completed	Phase 2	48	Alliance for Clinical Trials in OncologyOTHER	1	Jul 13, 2016